Hypertension in the critically ill patient

作者: Lindsay I G Worthley , R Santhi

DOI:

关键词:

摘要: Objective: To review the management of persistent hypertension and hypertensive crisis in critically ill patient. Data sources: A articles reported on Summary review: Hypertension is defined as a basal systolic blood pressure greater than 140 mmHg or diastolic 90 (MAP>105 mmHg), irrespective age based average two more readings occasions over period four weeks. While mean arterial up to value 135 may be tolerated for some hours, patients with dissecting aortic aneurysm, cardiac failure, angina, acute myocardial infarction, pre-eclampsia following cardiac, vascular cerebral surgery >90 should lowered by 30% urgently. MAP>160 can caused phaeochromocytoma, sympathomimetic overdose, malignant autonomic hyperreactivity secondary tetanus. Treatment requires direct intra-arterial monitoring an initial reduction no 30%. primary condition (eg surgical removal delivery termination pregnancy) also necessary, infusions sodium nitroprusside, phentolamine, hydralazine esmolol usually require supplementation oral agents angiotensin-converting enzyme inhibitors, beta adrenergic receptor antagonists calcium channel blockers) long term management. Conclusions: often hours. However disorders eclampsia surgery) treated (author abstract)

参考文章(116)
John Chalmers, The 1999 WHO-ISH Guidelines for the Management of Hypertension. The Medical Journal of Australia. ,vol. 171, pp. 458- 459 ,(1999) , 10.5694/J.1326-5377.1999.TB123747.X
Dean T. Mason, Afterload reduction and cardiac performance The American Journal of Medicine. ,vol. 65, pp. 106- 125 ,(1978) , 10.1016/0002-9343(78)90700-3
David O. Arnar, James B. Martins, John J. Cai, Hon Chi Lee, Erwin F. Shibata, Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 597- 606 ,(1996)
MICHAEL BORNEMANN, Lactic Acidosis in Pheochromocytoma Annals of Internal Medicine. ,vol. 105, pp. 880- 882 ,(1986) , 10.7326/0003-4819-105-6-880
Xiaoping Zhang, Yi-Wu Xie, Alberto Nasjletti, Xiaobin Xu, Michael S. Wolin, Thomas H. Hintze, ACE Inhibitors Promote Nitric Oxide Accumulation to Modulate Myocardial Oxygen Consumption Circulation. ,vol. 95, pp. 176- 182 ,(1997) , 10.1161/01.CIR.95.1.176
P. FOËX, ALPHA-AND BETA-ADRENOCEPTOR ANTAGONISTS BJA: British Journal of Anaesthesia. ,vol. 56, pp. 751- 765 ,(1984) , 10.1093/BJA/56.7.751
Haralambos Gavras, The Place of Angiotensin-Converting Enzyme Inhibition in the Treatment of Cardiovascular Diseases New England Journal of Medicine. ,vol. 319, pp. 1541- 1543 ,(1988) , 10.1056/NEJM198812083192310
John McMurray, David Murdoch, Calcium-antagonist controversy: the long and short of it? The Lancet. ,vol. 349, pp. 585- 586 ,(1997) , 10.1016/S0140-6736(05)61561-9
Michael B. Murphy, Clare Murray, George D. Shorten, Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. The New England Journal of Medicine. ,vol. 345, pp. 1548- 1557 ,(2001) , 10.1056/NEJMRA010253